iBio (IBIO) Preferred Dividend Payments (2017 - 2021)
iBio's (IBIO) quarterly Preferred Dividend Payments came in at $22000.0 in Q4 2021, down 66.15% year-on-year from $65000.0 in Q4 2020, and down 66.67% on a QoQ basis from $66000.0 in Q3 2021.
iBio (IBIO) Preferred Dividend Payments (2017 - 2021) Analysis & Trends
iBio (IBIO) has 5 years of Preferred Dividend Payments data on file, last reported at $22000.0 in Q4 2021.
- On a quarterly basis, Preferred Dividend Payments fell 66.15% year-over-year to $22000.0 in Q4 2021; TTM through Sep 2022 was $22000.0, a 91.54% decrease from a year earlier, with the FY2022 full-year figure at $88000.0, down 66.15% from the prior year.
- Preferred Dividend Payments for Q4 2021 stood at $22000.0, down from $66000.0 in the prior quarter.
- Over the last five years, Preferred Dividend Payments for IBIO reached as high as $66000.0 in Q3 2017 and fell as low as $22000.0 in Q4 2021.
- Historically, Preferred Dividend Payments has averaged $60950.0 across 5 years, with a median of $65000.0 in 2017.
- Across the five-year window, Preferred Dividend Payments jumped 146.15% in 2018 and slumped 66.15% in 2021, its largest moves.
- Year by year, Preferred Dividend Payments stood at $65000.0 in 2017, then changed by 0.0% to $65000.0 in 2018, then changed by 0.0% to $65000.0 in 2019, then changed by 0.0% to $65000.0 in 2020, then slumped by 66.15% to $22000.0 in 2021.
- Per Business Quant data, the three most recent Preferred Dividend Payments figures were $22000.0 in Q4 2021, $66000.0 in Q3 2021, and $65000.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - | - |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - | - |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | - |
| 10 | iBio | 166.84 Mn | 166.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 66,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 65,000.00 |
| Sep 30, 2020 | 66,000.00 |
| Jun 30, 2020 | 65,000.00 |
| Mar 31, 2020 | 65,000.00 |
| Dec 31, 2019 | 65,000.00 |
| Sep 30, 2019 | 66,000.00 |
| Jun 30, 2019 | 65,000.00 |
| Mar 31, 2019 | 64,000.00 |
| Dec 31, 2018 | 65,000.00 |
| Sep 30, 2018 | 66,000.00 |
| Jun 30, 2018 | 65,000.00 |
| Mar 31, 2018 | 64,000.00 |
| Dec 31, 2017 | 65,000.00 |
| Sep 30, 2017 | 66,000.00 |
| Jun 30, 2017 | 64,000.00 |
| Mar 31, 2017 | 26,000.00 |